Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting.
Neumann FJ, Gawaz M, Ott I, May A, Mössmer G, Schömig A. Neumann FJ, et al. Among authors: may a. J Am Coll Cardiol. 1996 Jan;27(1):15-21. doi: 10.1016/0735-1097(95)00433-5. J Am Coll Cardiol. 1996. PMID: 8522689 Free article.
BACKGROUND: Better hemostatic monitoring may improve antithrombotic therapy after stenting. METHODS: In 140 consecutive patients undergoing Palmaz-Schatz stent implantation for suboptimal angioplasty results, we obtained serial blood samples immediately before and daily fo …
BACKGROUND: Better hemostatic monitoring may improve antithrombotic therapy after stenting. METHODS: In 140 consecutive patients unde …
Platelet activation and coronary stent implantation. Effect of antithrombotic therapy.
Gawaz M, Neumann FJ, Ott I, May A, Schömig A. Gawaz M, et al. Among authors: may a. Circulation. 1996 Aug 1;94(3):279-85. doi: 10.1161/01.cir.94.3.279. Circulation. 1996. PMID: 8759067

Patients receiving anticoagulation therapy showed a significantly increased surface exposure of LIBS1 (activated fibrinogen receptor; P < .05) and CD62P (P-selectin; P < .001) above prestent values, peaking days 3 to 6 after stenting. ...CONCLUSIONS: Significant plat

…
Patients receiving anticoagulation therapy showed a significantly increased surface exposure of LIBS1 (activated fibrinogen receptor; …
Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation.
May AE, Neumann FJ, Gawaz M, Ott I, Walter H, Schömig A. May AE, et al. Eur Heart J. 1997 Dec;18(12):1913-20. doi: 10.1093/oxfordjournals.eurheartj.a015200. Eur Heart J. 1997. PMID: 9447319
BACKGROUND: Monocyte activation induces different procoagulant and proadhesive inflammatory responses and thus may play a role in thrombotic complications after coronary interventions. Monocyte-platelet interaction may trigger these effects inducing monocyte …
BACKGROUND: Monocyte activation induces different procoagulant and proadhesive inflammatory responses and thus may play a role …
Platelets in inflammation and atherogenesis.
Gawaz M, Langer H, May AE. Gawaz M, et al. J Clin Invest. 2005 Dec;115(12):3378-84. doi: 10.1172/JCI27196. J Clin Invest. 2005. PMID: 16322783 Free PMC article. Review.
Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation.
Geisler T, Langer H, Wydymus M, Göhring K, Zürn C, Bigalke B, Stellos K, May AE, Gawaz M. Geisler T, et al. Eur Heart J. 2006 Oct;27(20):2420-5. doi: 10.1093/eurheartj/ehl275. Epub 2006 Sep 27. Eur Heart J. 2006. PMID: 17005534 Clinical Trial.
Compared with patients who adequately responded to clopidogrel, a low responder had a significantly higher risk of major cardiovascular events [22.7 vs. 5.6%; odds ratio, 4.9; 95% confidence interval (CI), 1.66-14.96; P = 0.004]. ...The evaluation of low response to …
Compared with patients who adequately responded to clopidogrel, a low responder had a significantly higher risk of major cardi …
2,634 results